News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
247,382 Results
Type
Article (5907)
Company Profile (21)
Press Release (241454)
Multimedia
Podcasts (1)
Webinars (5)
Section
Business (87687)
Career Advice (470)
Deals (16489)
Drug Delivery (9)
Drug Development (21293)
Employer Resources (32)
FDA (4053)
Job Trends (4550)
News (129827)
Policy (8427)
Tag
Academia (338)
Accelerated approval (3)
Adcomms (4)
Allergies (10)
Alliances (16236)
ALS (28)
Alzheimer's disease (328)
Antibody-drug conjugate (ADC) (17)
Approvals (4083)
Artificial intelligence (63)
Autoimmune disease (8)
Automation (4)
Bankruptcy (107)
Best Places to Work (3389)
Biosimilars (19)
Biotechnology (28)
Bladder cancer (16)
Brain cancer (8)
Breast cancer (88)
Cancer (644)
Cardiovascular disease (33)
Career advice (402)
Career pathing (3)
CAR-T (44)
CDC (2)
Cell therapy (128)
Cervical cancer (2)
Clinical research (18010)
Collaboration (246)
Compensation (234)
Complete response letters (3)
COVID-19 (453)
CRISPR (13)
C-suite (161)
Cystic fibrosis (20)
Data (779)
Denatured (1)
Depression (12)
Diabetes (59)
Diagnostics (2275)
Digital health (4)
Diversity, equity & inclusion (14)
Drug discovery (30)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (18)
Earnings (43385)
Editorial (2)
Employer branding (6)
Employer resources (34)
Events (40986)
Executive appointments (390)
FDA (4465)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (280)
Gene editing (22)
Generative AI (2)
Gene therapy (60)
GLP-1 (142)
Government (514)
Guidances (94)
Healthcare (5575)
HIV (9)
Huntington's disease (3)
IgA nephropathy (8)
Immunology and inflammation (19)
Indications (10)
Infectious disease (475)
Inflammatory bowel disease (27)
Inflation Reduction Act (3)
Influenza (3)
Intellectual property (19)
Interviews (57)
IPO (8456)
IRA (3)
Job creations (1258)
Job search strategy (365)
Kidney cancer (9)
Labor market (5)
Layoffs (109)
Leadership (5)
Legal (2677)
Liver cancer (19)
Longevity (4)
Lung cancer (72)
Lymphoma (40)
Machine learning (1)
Management (11)
Manufacturing (79)
MASH (34)
Medical device (4324)
Medtech (4326)
Mergers & acquisitions (8361)
Metabolic disorders (160)
Multiple sclerosis (13)
NASH (6)
Neurodegenerative disease (16)
Neuropsychiatric disorders (2)
Neuroscience (477)
NextGen: Class of 2025 (1793)
Non-profit (796)
Now hiring (3)
Obesity (67)
Opinion (31)
Ovarian cancer (19)
Pain (20)
Pancreatic cancer (25)
Parkinson's disease (37)
Partnered (8)
Patents (39)
Patient recruitment (46)
Peanut (5)
People (26638)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (5341)
Phase II (7945)
Phase III (6199)
Pipeline (813)
Policy (11)
Postmarket research (658)
Preclinical (2124)
Press Release (67)
Prostate cancer (41)
Psychedelics (6)
Radiopharmaceuticals (120)
Rare diseases (103)
Real estate (2015)
Recruiting (9)
Regulatory (5738)
Reports (18)
Research institute (352)
Resumes & cover letters (68)
Rett syndrome (8)
RNA editing (3)
RSV (1)
Schizophrenia (32)
Series A (41)
Series B (31)
Service/supplier (2)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (31)
Sponsored (5)
Startups (1129)
State (1)
Stomach cancer (1)
Supply chain (14)
Tariffs (5)
Vaccines (70)
Venture capital (4)
Weight loss (25)
Women's health (3)
Date
Today (16)
Last 7 days (109)
Last 30 days (567)
Last 365 days (10453)
2025 (5605)
2024 (12221)
2023 (14522)
2022 (20432)
2021 (21855)
2020 (19711)
2019 (14319)
2018 (11021)
2017 (10891)
2016 (10005)
2015 (13164)
2014 (10359)
2013 (8349)
2012 (9039)
2011 (9446)
2010 (9259)
Location
Africa (200)
Alabama (16)
Alaska (2)
Arizona (72)
Arkansas (1)
Asia (12273)
Australia (1689)
California (2472)
Canada (1287)
China (97)
Colorado (111)
Connecticut (110)
Delaware (49)
Europe (26346)
Florida (382)
Georgia (46)
Idaho (24)
Illinois (130)
India (7)
Indiana (95)
Iowa (7)
Japan (113)
Kansas (26)
Kentucky (14)
Louisiana (6)
Maine (43)
Maryland (266)
Massachusetts (2035)
Michigan (118)
Minnesota (167)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (36)
New Hampshire (24)
New Jersey (869)
New Mexico (8)
New York (640)
North Carolina (400)
North Dakota (4)
Northern California (1181)
Ohio (75)
Oklahoma (8)
Oregon (4)
Pennsylvania (467)
Puerto Rico (2)
Rhode Island (14)
South America (307)
South Carolina (10)
Southern California (891)
Tennessee (54)
Texas (347)
United States (9308)
Utah (74)
Virginia (63)
Washington D.C. (15)
Washington State (212)
West Virginia (2)
Wisconsin (41)
247,382 Results for "genfit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
July 9, 2025
·
10 min read
Press Releases
GENFIT Reports First Quarter 2025 Financial Information
May 23, 2025
·
7 min read
Press Releases
GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update
April 25, 2025
·
26 min read
Press Releases
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
May 15, 2025
·
8 min read
Press Releases
GENFIT to Present Latest ACLF Research at EASL Congress 2025
May 5, 2025
·
12 min read
Press Releases
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
May 8, 2025
·
5 min read
Press Releases
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
April 30, 2025
·
5 min read
FDA
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis
Ipsen and Genfit’s elafibranor will now be marketed as Iqirvo and is the first new medicine approved in nearly a decade for the treatment of the rare liver disease, according to the companies.
June 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
May 21, 2025
·
5 min read
Press Releases
GENFIT Announces 2025 Financial Calendar
January 30, 2025
·
5 min read
1 of 24,739
Next
